Development of sustained release tablets with Compritol® 888 ATO – guidelines and practical tips
![Development of sustained release tablets with Compritol 888 ATO](https://www.pharmaexcipients.com/wp-content/uploads/2020/02/0VT0Z5922.jpg)
Compritol® 888 ATO combines several advantages when used as a sustained release matrix agent. These will be explained and illustrated throughout this Guideline.
Download Gattefossé guidelines and get practical tips for successful formulation of sustain release tablets with Compritol® 888 ATO – click on the Picture